Targeted Nanoparticles Boost Arsenic`s Anticancer Punch
Wednesday, July 22, 2009 - 12:49
in Health & Medicine
Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity of this material is likely to limit its utility as a broad-spectrum anticancer agent.